|Articles|April 15, 2021

COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 15, 2021

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

How many people in the US have been vaccinated against COVID-19?

According to the US Centers for Disease Control and Prevention, as of today, April 15, 2021, at 12:28 PM, EDT:

• 37.9% of total US population have received at least 1 dose
• 23.6% of total US population are fully vaccinated

The 5 states with the highest percentage of population fully vaccinated are:

1. Maine: 30.9%
2. Alaska: 30.8%
3. New Mexico: 30.5%
4. Rhode Island: 30.4%
5. Connecticut: 29.7%

How many cases of COVID-19 have been confirmed in the US?

According to the Johns Hopkins COVID-19 interactive map, as of today, April 15, 2021 at 1:21 PM, EDT, there have been:

• 31 455 995 confirmed cases
• 564 715 deaths

The 5 states with the highest total confirmed cases are:

1. California: 3 709 236
2. Texas: 2 841 029
3. Florida: 2 141 686
4. New York: 1 977 861
5. Illinois: 1 292 415

Deaths: California has the most deaths due to COVID-19 with 60 766 reported fatalities, followed by New York with 51 369, and Texas with 49 359.

How many cases of COVID-19 have been confirmed globally?

Globally, there have been 138 581 232 confirmed cases, 2 977 619 deaths, and 78 948 017 recoveries.

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Related to this article

September 3rd, 2026

FDA Approves Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine for 2026-27 Season

FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.

September 2nd, 2026

Independent Review Supports Respiratory Virus Immunizations for 2026-27 Season

A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.

August 25th, 2026

Pre-Vaccine Antibodies May Predict Blunted COVID-19 Vaccine Response

Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.

August 31st, 2026

FDA Approves Bixlenvo for HIV-1 Switch Therapy in Virologically Suppressed Adults

FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.

August 26th, 2026

FDA Expands Dolutegravir Approval to Infants With HIV-1 Weighing at Least 2 kg

FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.

August 11th, 2026

New Childhood Vaccine Executive Order Draws Criticism From AAP, AMA, NFID

The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.